Skip to main content
. 2023 Nov 14;6(11):e2343285. doi: 10.1001/jamanetworkopen.2023.43285

Figure 1. National Comprehensive Cancer Network (NCCN) Category of Evidence Ratings Stratified by US Food and Drug Administration (FDA) Approval Status.

Figure 1.

AA indicates accelerated approval.